New video game aims to boost immune system against breast cancer

NCT ID NCT07357207

ENROLLING_BY_INVITATION Symptom relief Sponsor: Izmir Biomedicine and Genome Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a mobile game called UMAY that helps breast cancer patients imagine their immune cells attacking cancer cells. 80 women with locally advanced breast cancer will play the game or a placebo game at home alongside their usual chemotherapy. Researchers will measure changes in symptoms, mood, and immune cell activity to see if this playful form of guided imagery can improve well-being and possibly help the body fight cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: UMAY video-immunotherapy game (a mobile app game where players visualize immune cells fighting cancer)
What this could lead to: If it works, this could offer a simple, fun way for breast cancer patients to support their immune system and feel better during chemotherapy.
What could go wrong: This is a small, early-stage study (80 people) testing a behavioral intervention, not a drug. The effects on the immune system or disease are uncertain, and it may not lead to any medical benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEMALE BREAST CANCER PATIENTS

Contacts and locations

Locations

Akdeniz University Hospital

Antalya, Konyaaltı, 07070, Turkey (Türkiye)
Antalya Training and Research Hospital

Antalya, Muratpasa, 07100, Turkey (Türkiye)
Dokuz Eylul University Hospital

Izmir, Balcova, 35340, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.